Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

November 30, 2023

Study Completion Date

January 15, 2024

Conditions

Diabetic Macular Edema (DME)

Interventions

DRUG

Intravitreal Bevacizumab IVB

Intravitreal bevacizumab alone

DRUG

intravitreal bevacizumab and suprachoroidal triamcinolone acetonide

Combination of Intravitreal bevacizumab and suprachoroidal triamcinolone acetonide

Trial Locations (1)

Khyber Teaching Hospital, Peshawar

All Listed Sponsors

lead

Khyber Teaching Hospital

OTHER